Sanofi – Display Banners Conference – Dec – 85690

Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.

Key risk factors for progression independent of relapse activity in relapsing-remitting MS include age and longer disease duration.

More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.

For patients with primary progressive MS, age is a particularly important factor that predicts disease activity.

Check out the key presentations from AAN Fall Clinical on MS. And follow along for more from AAN.

Take a look at the schedule for AAN Fall Conference. And follow along at PW for conference coverage.

Take a look at some of the fun facts about AAN Fall Conference. And follow PW for conference coverage.